HomePTPI • NASDAQ
add
Petros Pharmaceuticals Inc
Previous close
$0.35
Day range
$0.32 - $0.37
Year range
$0.31 - $4.03
Market cap
2.56M USD
Avg Volume
514.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.39M | -44.84% |
Operating expense | 4.99M | 52.15% |
Net income | -2.16M | -56.13% |
Net profit margin | -155.72 | -183.08% |
Earnings per share | -1.69 | — |
EBITDA | -3.21M | -565.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.08M | 33.18% |
Total assets | 30.31M | -0.84% |
Total liabilities | 19.62M | 29.73% |
Total equity | 10.69M | — |
Shares outstanding | 7.00M | — |
Price to book | 0.25 | — |
Return on assets | -30.64% | — |
Return on capital | -49.62% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.16M | -56.13% |
Cash from operations | -1.13M | -51.64% |
Cash from investing | — | — |
Cash from financing | -1.12M | -213.39% |
Net change in cash | -2.26M | -103.97% |
Free cash flow | -1.08M | -132.13% |
About
Founded
2020
Website
Employees
21